BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25985629)

  • 1. [Regulation of cancer behavior mediated by mTOR signal].
    Hirao A
    Nihon Rinsho; 2015 May; 73(5):773-8. PubMed ID: 25985629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roles of mTOR signalings in hematopoiesis and leukemogenesis].
    Hirao A
    Rinsho Ketsueki; 2015 Jun; 56(6):601-5. PubMed ID: 26256868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [mTOR inhibitor].
    Muro K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
    Hirao A; Hoshii T
    Cancer Sci; 2013 Aug; 104(8):977-82. PubMed ID: 23648144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR signaling pathway and mTOR inhibitors in cancer therapy.
    Gomez-Pinillos A; Ferrari AC
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):483-505, vii. PubMed ID: 22520976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Ghosh J; Kapur R
    Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the mTOR pathway in tumor malignancy.
    Cheng H; Walls M; Baxi SM; Yin MJ
    Curr Cancer Drug Targets; 2013 Mar; 13(3):267-77. PubMed ID: 23297825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mTOR for cancer therapy.
    Hua H; Kong Q; Zhang H; Wang J; Luo T; Jiang Y
    J Hematol Oncol; 2019 Jul; 12(1):71. PubMed ID: 31277692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.
    Tian T; Li X; Zhang J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inhibitor for the treatment of hepatocellular carcinoma.
    Kudo M
    Dig Dis; 2011; 29(3):310-5. PubMed ID: 21829022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inhibitors in cancer therapy.
    Zaytseva YY; Valentino JD; Gulhati P; Evers BM
    Cancer Lett; 2012 Jun; 319(1):1-7. PubMed ID: 22261336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease.
    Leo MS; Sivamani RK
    Arch Dermatol Res; 2014 Dec; 306(10):861-71. PubMed ID: 24972910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR: Role in cancer, metastasis and drug resistance.
    Murugan AK
    Semin Cancer Biol; 2019 Dec; 59():92-111. PubMed ID: 31408724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
    Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
    Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro.
    Ayuk SM; Abrahamse H
    Cells; 2019 May; 8(5):. PubMed ID: 31075885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment.
    Lv X; Ma X; Hu Y
    Expert Opin Drug Discov; 2013 Aug; 8(8):991-1012. PubMed ID: 23668243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.